CA2510228C — 25-so2-substituted analogs of 1.alpha.,25-dihydroxyvitamin d3
Assigned to Cytochroma Inc · Expires 2012-10-30 · 14y expired
What this patent protects
The present invention provides novel analogs of 1.alpha.,25-dihydroxyvitamin of formula Ia and Ib: (see formula Ia) (see formula Ib), compositions comprising these compounds and methods of using these compounds as selective inhibitors of CYP24. In particular, the compounds of t…
USPTO Abstract
The present invention provides novel analogs of 1.alpha.,25-dihydroxyvitamin of formula Ia and Ib: (see formula Ia) (see formula Ib), compositions comprising these compounds and methods of using these compounds as selective inhibitors of CYP24. In particular, the compounds of the invention are useful for treating diseases which benefit from a modulation of the levels of 1.alpha.,25-dihydroxyvitamin D3, for example, cell-proliferative disorders.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.